About William Mccarthy
Form D filings for Genesis Therapeutics from 2022 to 2023 list William Mccarthy as executive officer.
William Mccarthy first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name William Mccarthy in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people William Mccarthy works with at each company, as listed on that company's latest Form D.
Genesis Therapeutics, Inc. · Form D, Aug 25, 2023
VP
Vijay Pande
Director
EF
Evan Feinberg
PRESIDENT and CEO, director
PP
Peptiboon Prasit
Executive officer and director
LB
Leonard Bell
Director
KJ
Kris Jenner
Director
BS
Benjamin Sklaroff
Executive officer